Guidelines for Economic Evaluation of Pharmaceuticals in Korea / 예방의학회지
Journal of Preventive Medicine and Public Health
;
: 80-83, 2008.
Article
in Korean
| WPRIM
| ID: wpr-15552
ABSTRACT
An economic evaluation is required in order to apply to the Health Insurance Review and Assessment Service (HIRA) for a listing in the national drug formulary. To assist companies in preparing the necessary documents, HIRA published guidelines for the economic evaluation of pharmaceuticals in 2006. The guidelines are composed of two parts guidance an explanatory notes. Each guideline reflects the best practice which meets both the theoretical consensus within the academic community and local situations, like data availability. To enhance the transparency of evaluation, guidelines emphasize the reproducibility of data and analysis result. That is, all evaluation processes are required to be described in enough detail to be replicated by reviewers. With growing experience and theoretical development in this area, HIRA guidelines will be revised periodically.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pharmaceutical Preparations
/
Cost-Benefit Analysis
/
Guidelines as Topic
/
Economics, Pharmaceutical
/
Korea
Type of study:
Practice guideline
/
Health economic evaluation
Limits:
Humans
Country/Region as subject:
Asia
Language:
Korean
Journal:
Journal of Preventive Medicine and Public Health
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS